This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Changing Landscape of the Cancer Genome
Organizer(s): Lynda Chin, Christoph Lengauer and Michael Stratton
Date: June 20 - 25, 2011
Location: Boston Park Plaza, Boston, MA, USA
Sponsored by Bayer USA Foundation, Novartis Institutes for BioMedical Research, Onyx Pharmaceuticals, Inc., and Pfizer Inc.
Summary of Meeting:
Large scale cancer-genomics across the globe are capturing increasingly detailed views of the cancer genomes. These data have the potential to transform every aspect of cancer research. The challenges now are to decipher what the genomic landscape is teaching us about the initiation, progression and clinical behavior of a tumor. The goals of this meeting are (1) to bring together the data producers and analysts to share their latest findings, both technical and biological, from large-scale cancer genomic projects and address the challenges in analyses of these complex cancer genomic data; (2) to highlight how these genomic data are enabling a system/network-view of the genome and how the patterns of mutations are teaching new insight into underlying etiologies; and (3) to explore how cancer genomics can impact on drug discovery and development.
Scholarship Deadline: February 21 2011
Discounted Abstract Deadline: March 7 2011
Abstract Deadline: March 21 2011
Discounted Registration Deadline: April 20 2011
We gratefully acknowledge additional support for this conference from:
Bayer USA FoundationIntegrated DNA TechnologiesNovartis Institutes for BioMedical ResearchOnyx Pharmaceuticals, Inc.Pfizer Inc.
We gratefully acknowledge the generous grant for this conference provided by:

National Cancer Institute (NCI)
Grant No. 1R13CA159787-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found